2,4-二氯-N-(異丙基)-N-[2-[(異丙基)氨基]乙基]苯磺酰胺
中文名稱 | 2,4-二氯-N-(異丙基)-N-[2-[(異丙基)氨基]乙基]苯磺酰胺 |
---|---|
中文同義詞 | 2,4-二氯-N-(異丙基)-N-[2-[(異丙基)氨基]乙基]苯磺酰胺;化合物RN-1734;2,4-二氯-N-(1-甲基乙基)-N-[2-[(1-甲基乙基)氨基]乙基]苯磺酰胺;TRPV4 ANTAGONIST I, RN-1734 CALBIOCHEM;RN-1734,TRPV4拮抗劑;化合物RN-1734,10 MM DMSO 溶液 |
英文名稱 | 2,4-dichloro-N-isopropyl-N-[2-(isopropylamino)ethyl]benzenesulfonamide |
英文同義詞 | 2,4-dichloro-N-isopropyl-N-[2-(isopropylamino)ethyl]benzenesulfonamide;RN 1734;2,4-Dichloro-N-isopropyl-N-(2-isopropylaminoethyl)benzenesulphonamide (RN-1734);2,4-Dichloro-N-(1-methylethyl)-N-[2-[(1-methylethyl)amino]ethyl]benzenesulfonamide;TRPV4 Antagonist I, RN-1734;TRPV4 Antagonist I, RN-1734 - CAS 946387-07-1 - Calbiochem;2,4-dichloro-N-propan-2-yl-N-[2-(propan-2-ylamino)ethyl]benzenesulfonamide;Benzenesulfonamide, 2,4-dichloro-N-(1-methylethyl)-N-[2-[(1-methylethyl)amino]ethyl]- |
CAS號 | 946387-07-1 |
分子式 | C14H22Cl2N2O2S |
分子量 | 353.31 |
EINECS號 | |
相關(guān)類別 | |
Mol文件 | 946387-07-1.mol |
結(jié)構(gòu)式 |
2,4-二氯-N-(異丙基)-N-[2-[(異丙基)氨基]乙基]苯磺酰胺 性質(zhì)
儲存條件 | 2-8°C |
---|---|
溶解度 | 二甲基亞砜:>20mg/mL |
形態(tài) | 黃色固體 |
顏色 | 白色至類白色 |
Target | Value |
TNF-α
() | |
IL-1β
() | |
hTRPV4
(Cell-free assay) | 2.3 μM |
rTRPV4
(Cell-free assay) | 3.2 μM |
mTRPV4
(Cell-free assay) | 5.9 μM |
RN-1734 (27 hours; 10μM) reverses the increase in the apoptotic rate of oligodendrocytes induced by CM (LPS-activated microglia group) apoptosis.
RN-1734 (27 hours; 10μM) alleviates CM-induced decreases in CNP.
Apoptosis Analysis
Cell Line: | Microglial cells |
Concentration: | 27 hours |
Incubation Time: | 10μM |
Result: | Significantly decreased the percentage of cleaved-caspase 3 positive cells. |
Western Blot Analysis
Cell Line: | Microglial cells |
Concentration: | 27 hours |
Incubation Time: | 10 μM |
Result: | Alleviated CM (with LPS only)-induced decreases in CNP. |
RN-1734 (0.5 μl; microinjector pump; daily for 5 weeks) significantly reverses the decrease in CNP protein and improves myelination in CPZ-induced demyelination mouse.
Animal Model: | CPZ-induced demyelination mouse model (C57BL/6 male mice) |
Dosage: | 0.5 μl (10 μM in 5% DMSO and 0.9% NaCl) |
Administration: | Microinjector pump for 5 weeks |
Result: | Significantly reversed the decrease in CNP protein and improved myelination in CPZ-induced demyelination mouse. |
安全信息
WGK Germany | nwg |
---|
更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
---|---|---|---|---|---|
2024/11/08 | HY-19975 | RN-1734 | 1 mg | 220元 | |
2024/11/08 | HY-19975 | 2,4-二氯-N-(異丙基)-N-[2-[(異丙基)氨基]乙基]苯磺酰胺 RN-1734 | 946387-07-1 | 5mg | 550元 |